Get the Stockscreener App
10.45
0.58%
0.10
Envveno Medical Corporation stock is traded at $10.45, with a volume of 11,125.
It is up +0.58% in the last 24 hours and down -0.95% over the past month.
enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.
See More
Previous Close:
$10.35
Open:
$10.38
24h Volume:
11,125
Relative Volume:
0.55
Market Cap:
$6.93M
Revenue:
-
Net Income/Loss:
$-24.05M
P/E Ratio:
-4.8605
EPS:
-2.15
Net Cash Flow:
$-17.78M
1W Performance:
+4.20%
1M Performance:
-0.95%
6M Performance:
-66.71%
1Y Performance:
-91.57%
1-Day Range:
$9.86
$11.42
1-Week Range:
$9.86
$12.70
52-Week Range:
$8.67
$196.70
Envveno Medical Corporation Stock (NVNO) Company Profile
Name
Envveno Medical Corporation
Sector
Industry
Phone
949-261-2900
Address
70 DOPPLER, IRVINE
Compare NVNO vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NVNO
Envveno Medical Corporation
|
10.57 | 6.79M | 0 | -24.05M | -17.78M | -2.15 |
|
ABT
Abbott Laboratories
|
116.17 | 199.55B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
386.03 | 146.96B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
96.98 | 123.91B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
75.64 | 109.04B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
85.83 | 48.40B | 6.07B | 1.06B | 799.60M | 1.8527 |
Envveno Medical Corporation Stock (NVNO) Latest News
enVVeno Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement - Shelby Star
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Fed Watch: Can enVVeno Medical Corporation maintain sales growthMarket Volume Report & Verified Chart Pattern Trade Signals - baoquankhu1.vn
enVVeno Medical Announces Reverse Stock Split - The Florida Times-Union
Strategic Investor Acquires Significant Stake in enVVeno Medical - AD HOC NEWS
Aug Analyst Calls: Is enVVeno Medical Corporation a strong candidate for buy and hold2025 Risk Factors & Short-Term High Return Ideas - baoquankhu1.vn
Head to Head Analysis: LENSAR (NASDAQ:LNSR) versus enVVeno Medical (NASDAQ:NVNO) - Defense World
enVVeno Receives Unfavorable Appeal Decision from the FDA for the VenoValve - The Northwest Florida Daily News
enVVeno Medical (NASDAQ:NVNO) to Participate in a Live Virtual Investor CEO Connect Segment - DelmarvaNow.com
enVVeno Medical Regains Nasdaq Compliance, Supports 2026 Plans - The Globe and Mail
EnVVeno Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement - News Channel Nebraska Southeast
enVVeno Medical regains Nasdaq compliance, reports $28 million cash By Investing.com - Investing.com Nigeria
enVVeno Medical regains compliance with Nasdaq minimum bid price rule - TipRanks
enVVeno Medical Regains Nasdaq Compliance - Orange County Business Journal
enVVeno Medical regains Nasdaq compliance, reports $28 million cash - Investing.com
Bank Watch: Is enVVeno Medical Corporation a strong candidate for buy and hold2025 Performance Recap & Smart Investment Allocation Tips - baoquankhu1.vn
enVVeno Medical Reports Third Quarter 2025 Financial Results and Provides Corporate Update - Green Bay Press-Gazette
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Breakout Zone: Why is Pliant Therapeutics Inc stock going upJuly 2025 Macro Moves & Expert Verified Stock Movement Alerts - baoquankhu1.vn
Volume Report: Will enVVeno Medical Corporation benefit from seasonalityShort Setup & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Highs Report: Is enVVeno Medical Corporation trading at a discount2025 Support & Resistance & Long Hold Capital Preservation Tips - baoquankhu1.vn
enVVeno Medical Executes One-for-35 Reverse Stock Split - TipRanks
EnVVeno Medical announces reverse stock split; shares down 20% - MSN
enVVeno Medical announces RSS - Medical Buyer
Midday Stock Roundup: loanDepot Jumps on Trump’s Proposed Mortgage Plan - Orange County Business Journal
Do Not Use - ocbj.com
enVVeno Medical Stock Set to Reverse Split on Tuesday, January 20th (NASDAQ:NVNO) - Defense World
Envveno Medical Corporation Stock (NVNO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.18%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):